Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma (AM) in patients with concomitant chronic lymphocytic leukemia (CLL)

被引：0
|
作者：
Cass, Samuel
Tobin, Joshua
Seo, Dave
Gener-Ricos, Georgina
Keung, Emily
Burton, Elizabeth
Davies, Michael
McQuade, Jennifer
Hampel, Paul
Wargo, Jennifer
Ferrajoli, Alessandra
机构：
来源：
LEUKEMIA & LYMPHOMA | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1552244
引用
收藏
页码：S129 / S130
页数：2
相关论文
共 50 条
  • [31] B Cell Subsets and Immune Checkpoint Expression in Patients with Chronic Lymphocytic Leukemia
    Ntsethe, Aviwe
    Mkhwanazi, Zekhethelo Alondwe
    Dludla, Phiwayinkosi Vusi
    Nkambule, Bongani Brian
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (03) : 1731 - 1740
  • [32] Greek Consensus on Chronic Lymphocytic Leukemia (CLL) Treatment
    Sachanas, Sotirios
    Vassilakopoulos, Theodoros
    Angelopoulou, Maria
    Papageorgiou, Sotirios
    Spanoudakis, Emmanouil
    Bouzani, Maria
    Dimou, Maria
    Panagiotidis, Panagiotis
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2025, 17 (01)
  • [33] A Single Institutional Experience of Immune Checkpoint Inhibitors in the Treatment of Advanced Mucosal Melanoma
    Kuo, James C.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 147 - 147
  • [34] Combining immune checkpoint inhibitors for advanced melanoma: the key to optimizing treatment outcomes?
    Freeston, Sarah
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2016, 5 (04) : 329 - 333
  • [35] Concomitant or Sequential Chronic Lymphocytic Leukemia (CLL) and Chronic Myeloid Leukemia (CML): A Molecular and Clinical Survey
    Said, Carla
    Heimann, P.
    Dessars, B.
    Phong, Dinh
    Cantiniaux, B.
    Cantiniaux, B.
    Meuleman, N.
    Bron, D.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 (06): : E34 - E34
  • [36] Immune Checkpoint Inhibitors in the Treatment of Metastatic Melanoma
    Mier, James W.
    CLINICAL THERAPEUTICS, 2015, 37 (04) : 753 - 754
  • [37] Efficacy and toxicities of immune checkpoint inhibitors (ICIs) in advanced melanoma: A single institution experience
    Welaya, Karim
    Baran, Andrea M.
    Lekkala, Manidhar Reddy
    Sahasrabudhe, Deepak M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05)
  • [38] Immune checkpoint inhibitors: a milestone in the treatment of melanoma
    Wilden, Sophia M.
    Lang, Berenice M.
    Mohr, Peter
    Grabbe, Stephan
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 (07): : 685 - 695
  • [39] Efficacy of immune checkpoint inhibitors in different types of melanoma
    Rossi, Ernesto
    Schinzari, Giovanni
    Maiorano, Brigida Anna
    Indellicati, Giulia
    Di Stefani, Alessandro
    Pagliara, Monica Maria
    Fragomeni, Simona Maria
    De Luca, Erika Valentina
    Sammarco, Maria Grazia
    Garganese, Giorgia
    Galli, Jacopo
    Blasi, Maria Antonietta
    Paludetti, Gaetano
    Scambia, Giovanni
    Peris, Ketty
    Tortora, Giampaolo
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (01) : 4 - 13
  • [40] Efficacy of immune checkpoint inhibitors for in-transit melanoma
    Nan Tie, Emilia
    Lai-Kwon, Julia
    Rtshiladze, Michael Alexander
    Na, Lumine
    Bozzi, James
    Read, Tavis
    Atkinson, Victoria
    Au-Yeung, George
    Long, Georgina
    McArthur, Grant A.
    Sandhu, Shahneen
    Saw, Robyn
    Walpole, Euan
    Menzies, Alexander
    Smithers, Mark
    Gyorki, David E.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
12345